A subscription to JoVE is required to view this content. Sign in or start your free trial.
We describe a preclinical experimental method to evaluate metabolic neuromodulation induced by acute deep brain stimulation with in vivo FDG-PET. This manuscript includes all experimental steps, from stereotaxic surgery to the application of the stimulation treatment and the acquisition, processing, and analysis of PET images.
Deep brain stimulation (DBS) is an invasive neurosurgical technique based on the application of electrical pulses to brain structures involved in the patient's pathophysiology. Despite the long history of DBS, its mechanism of action and appropriate protocols remain unclear, highlighting the need for research aiming to solve these enigmas. In this sense, evaluating the in vivo effects of DBS using functional imaging techniques represents a powerful strategy to determine the impact of stimulation on brain dynamics. Here, an experimental protocol for preclinical models (Wistar rats), combined with a longitudinal study [18F]-fluorodeoxyclucose positron emission tomography (FDG-PET), to assess the acute consequences of DBS on brain metabolism is described. First, animals underwent stereotactic surgery for bilateral implantation of electrodes into the prefrontal cortex. A post-surgical computerized tomography (CT) scan of each animal was acquired to verify electrode placement. After one week of recovery, a first static FDG-PET of each operated animal without stimulation (D1) was acquired, and two days later (D2), a second FDG-PET was acquired while animals were stimulated. For that, the electrodes were connected to an isolated stimulator after administering FDG to the animals. Thus, animals were stimulated during the FDG uptake period (45 min), recording the acute effects of DBS on brain metabolism. Given the exploratory nature of this study, FDG-PET images were analyzed by a voxel-wise approach based on a paired T-test between D1 and D2 studies. Overall, the combination of DBS and imaging studies allows describing the neuromodulation consequences on neural networks, ultimately helping to unravel the conundrums surrounding DBS.
The term neurostimulation encompasses a number of different techniques aimed at stimulating the nervous system with a therapeutic objective1. Among them, deep brain stimulation (DBS) stands out as one of the most widespread neurostimulation strategies in clinical practice. DBS consists of the stimulation of deep brain nuclei with electrical pulses delivered by a neurostimulator, implanted directly into the patient's body, through electrodes placed into the brain target to be modulated by stereotactic surgery. The number of articles evaluating the feasibility of DBS application in different neurological and psychiatric disorders is continuou....
Experimental animal procedures were conducted according to the European Communities Council Directive 2010/63/EU, and approved by the Ethics Committee for Animal Experimentation of the Hospital Gregorio Marañón. A graphical summary of the experimental protocol is shown in Figure 1A.
1. Brain target localization by in vivo neuroimaging
The animals were sacrificed using CO2 at the end of the study or when the animal’s welfare was compromised. An example of a complete PET/CT study from an operated animal is shown in Figure 3. Thus, the electrode inserted into the rat brain can be clearly observed in the CT image shown in Figure 3A. This imaging modality provides good anatomical information and facilitates the registration of FDG-PET images, given that functional modalities .......
Given the advances in the understanding of brain function and the neural networks involved in the pathophysiology of neuropsychiatric disorders, more and more research is recognizing the potential of DBS in a wide range of neurologically-based pathologies2. However, the mechanism of action of this therapy remains unclear. Several theories have attempted to explain the effects obtained in specific pathological and stimulation circumstances, but the heterogeneity of the proposed studies makes it ver.......
We thank Prof. Christine Winter, Julia Klein, Alexandra de Francisco and Yolanda Sierra for their invaluable support in the optimization of the methodology here described. MLS was supported by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III (project number PI17/01766 and grant number BA21/0030) co- financed by European Regional Development Fund (ERDF), "A way to make Europe"; CIBERSAM (project number CB07/09/0031); Delegación del Gobierno para el Plan Nacional sobre Drogas (project number 2017/085); Fundación Mapfre; and Fundación Alicia Koplowitz.
Name | Company | Catalog Number | Comments |
7-Tesla Biospec 70/20 scanner | Bruker, Germany | SN0021 | MRI scanner for small animal imaging |
Betadine | Meda Pharma S.L., Spain | 644625.6 | Iodine solution (iodopovidone) |
Beurer IL 11 | Beurer | SN87318 | Infra-red light |
Bipolar cable 50 cm w/50 cm mesh covering up to 100 cm | Plastics One, USA | 305-305 (CM) | |
Bipolar cable TT2 50 cm up to 100 cm | Plastics One, USA | 305-340/2 | Bipolar cable TT2 50 cm up to 100 cm |
Buprex | Schering-Plough, S.A | 961425 | Buprenorphine (analgesic) |
Ceftriaxona Reig Jofré 1g IM | Laboratorio Reig Jofré S.A., Spain | 624239.1 | Ceftriaxone (antibiotic) |
Commutator | Plastics One, USA | SL2+2C | 4 Channel Commutator for DBS |
Concentric bipolar platinum-iridium electrodes | Plastics One, USA | MS303/8-AIU/Spc | Electrodes for DBS |
Driller | Bosh | T58704 | Driller |
FDG | Curium Pharma Spain S.A., Spain | ----- | 2-[18F]fluoro-2-deoxy-D-glucose (PET radiotracer) |
Heating pad | DAGA, Spain | 23115 | Heating pad |
Ketolar | Pfizer S.L., Spain | 776211.9 | Ketamine (anesthetic drug) |
Lipolasic 2 mg/g | Bausch & Lomb S.A, Spain | 65277 | Ophthalmic lubricating gel |
MatLab R2021a | The MathWorks, Inc | Support software for SPM12 | |
MRIcro | McCausland Center for Brain Imaging, University of South Carolina, USA | v2.1.58-0 | Software for imaging preprocessing and analysis |
Multimodality Workstation (MMWKS) | BiiG, Spain | Software for imaging processing and analysis | |
Omicrom VISION VET | RGB Medical Devices, Spain | 731100 ReV B | Cardiorrespiratory monitor for small imaging |
Prevex Cotton buds | Prevex, Finland | ----- | Cotton buds |
Sevorane | AbbVie Spain, S.L.U, Spain | 673186.4 | Sevoflurane (inhalatory anesthesia) |
Small screws | Max Witte GmbH | 1,2 x 2 DIN 84 A2 | Small screws |
Standard U-Frame Stereotaxic Instrument for Rat, 18° Ear Bar | Harvard Apparatus, USA | 75-1801 | Two-arms Stereotactic frame for rat |
Statistical Parametric Mapping (SPM12) | The Wellcome Center for Human Neuroimaging, UCL Queen Square Institute of Neurology, UK | SPM12 | Software for voxel-wise imaging analysis |
STG1004 | Multi Channel Systems GmbH, Germany | STG1004 | Isolated stimulator |
SuperArgus PET/CT scanner | Sedecal, Spain | S0026403 | NanoPET/CT scanner for small animal imaging |
Suture thread with needle, 1/º | Lorca Marín S.A., Spain | 55325 | Braided natural silk non-absorbable suture 1/0, with triangle needle |
Technovit 4004 (powder and liquid) | Kulzer Technique, Germany | 64708471; 64708474 | Acrylic dental cement for craniotomy tap |
Wistar rats (Rattus norvergicus) | Charles River, Spain | animal facility | Animal model used |
Xylagesic | Laboratorios Karizoo, A.A, Spain | 572599-4 | Xylazine (anesthetic drug) |
Normon S.A., Spain | 602910 | Mepivacaine in gel for topical use |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved